Cinemark Holdings, Inc. · NYSE:CNK
Cinemark — Q3 2022 Earnings Presentation
23 slides from Cinemark's earnings presentation, Nov 4, 2022
Slide 1: Investor Presentation
Investor Presentation November 4, 2022
Slide 2: Forward Looking Statements
Forward Looking Statements CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS PURSUANT TO THE U.S. PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: This presentation contains, and our officers and representatives may from time to time make, “forward–looking statements” within the meaning of the s
Slide 3: Cinemark Overview
Cinemark Overview
Slide 4: Cinemark Overview
Cinemark Overview One of the largest and most influential theatrical exhibition companies in the world with 517 theaters with 5,835 screens in 16 countries (1) U.S. Operations (2) • 3rd largest exhibitor (screen count) • 42 states, 104 DMAs • #1 or #2 in box office revenues in 80% of our top 25 mark
Slide 5: Highly Experienced Management Team
Highly Experienced Management Team Highly experienced management team with significant industry experience and proven track records; Additional key leaders with 20+ years of industry/Cinemark experience in the US and internationally Sean Gamble Valmir Fernandes President & CEO President, Internation
Slide 6: Exhibition Industry Trends
Exhibition Industry Trends Stable, long-term industry growth trends across technology innovations and economic cycles; industry continuing to recover from COVID pandemic North America Box Office Trends Recliners and enhanced food Digital projector conversion Investments DVD player drops to$100 Reces
Slide 7: Pre-COVID Summary & Financials
Pre-COVID Summary & Financials
Slide 8: Broad and Leading Presence in the Americas
Broad and Leading Presence in the Americas Strong presence across the U.S. and Latin America that is strategically important to film distributors as well as promotional partners 2019 Market Share - North America (1) 2019 Market Share - Key Latin American Markets (1) Cinemark 27% Cinepolis 37% AMC Ki
Slide 9: Initiatives to Drive Growth and Outperformance
Initiatives to Drive Growth and Outperformance Capex cycle peaked in 2015 – 2019, with investments that drove long-term customer engagement and positioned the company for ongoing success Heightened focus on the guest 67% U.S. recliner penetration - experience; guest service scores highest among majo
Slide 10: Consistent Industry Outperformance
Consistent Industry Outperformance Cinemark has surpassed North American industry box office growth 12 out of the past 13 years and has consistently led the industry in Adjusted EBITDA margin (1) 2014 - 2019 Admission Revenue Growth (2) CNK Worldwide Adjusted EBITDA Growth (2,3) 22.9% +6% $745 CAGR
Slide 11: 2019 Financial Summary
2019 Financial Summary 2019 Worldwide Results (1) Highlights • Served ~280 million patrons globally 2019 5-Year CAGR • Achieved 5th consecutive year of record revenue with top-line Attendance 280 1.2% growth in U.S. and International3 segments • Exceeded North America industry box office growth by 2
Slide 12: Recovery Update and Financial Results
Recovery Update and Financial Results
Slide 13: Highlights of Third Quarter 2022 Results
Highlights of Third Quarter 2022 Results We continue to make significant progress in recovering from the effects of the pandemic and are extremely well-positioned to benefit from the ongoing resurgence of theatrical moviegoing • Domestic box office outperformed the North American industry results by
Slide 14: Third Quarter 2022 Financial Summary
Third Quarter 2022 Financial Summary Q3 Worldwide Results (1) (2) Q3 2022 Highlights Q3 Q3 Q3 • Worldwide revenue grew 50% year-over-year with Adj. EBITDA up 125%, underscoring our ongoing recovery 2022 2021 2019 • Delivered 80% of 3Q19’s total revenue with only 65% of the Attendance 48.4 30.7 73.3
Slide 15: A Look Ahead
A Look Ahead
Slide 16: Near-Term Priorities to Drive Operating Success
Near-Term Priorities to Drive Operating Success Sustained progress in advancing our consumer, growth, and productivity initiatives to capitalize on the ongoing recovery of theatrical exhibition and position the company for long-term success Create an exceptional guest experience through premium amen
Slide 17: 4Q 2022 Notable Titles
4Q 2022 Notable Titles A more consistent cadence of films with broad consumer appeal results in a compelling fourth quarter lineup to finish the year strong September 16 October 14 October 21 October 21 Q3 Carryover Q4 Releases September 23 October 28 November 11 November 25 September 30 December 16
Slide 18: 2023 Notable Titles
2023 Notable Titles 2023 expected to be a further year of recovery and improvement in content volume and box office Q1 January 13 February 17 March 3 March 3 March 17 March 24 Q2 April 7 May 19 May 5 May 26 June 2 June 23 Q3 June 30 July 14 July 21 July 21 July 28 August 4 Q4 November 17 November 17
Slide 19: Value of an Exclusive Theatrical Window
Value of an Exclusive Theatrical Window Theatrical exhibition provides a premium consumer experience that helps ‘eventize’ content and elevate perception of content, enhancing long-term value of film assets for studios Premium Out-of-Home Entertainment Experience The shared, larger-than-life cinemat
Slide 20: Appendix
Appendix
Slide 21: FY 2021 Non-GAAP Measure Reconciliations
FY 2021 Non-GAAP Measure Reconciliations Reconciliation of Net Income/(Loss) to Adjusted EBITDA(1) Reconciliation of Cash Flows (Used for) Provided by Operating Activities to Free Cash Flow(1) FY 2021 FY 2019 FY 2021 FY 2019 Net Income/(Loss) ($422.2) $193.8 Cash flows (used for) provided by operati
Slide 22: 3Q 2022 Non-GAAP Measure Reconciliations
3Q 2022 Non-GAAP Measure Reconciliations Reconciliation of Net Income/(Loss) to Adjusted EBITDA(1) Reconciliation of Cash Flows (Used for) Provided by Operating Activities to Free Cash Flow(1) 3Q 2022 3Q 2021 3Q 2019 3Q 2022 3Q 2021 3Q 2019 Net Income/(Loss) ($23.9) ($77.6) $32.0 Cash flows (used fo
Slide 23: Thank You
Thank You Chanda Brashears SVP Investor Relations cbrashears@cinemark.com 972-665-1671